ImmunityBio: Market Has Lost Contact Following Merger

koto_feja/E+ via Getty Images
Earlier this year, ImmunityBio (IBRX) and NantKwest merged and formed an innovative immunotherapy company that has an all-encompassing pipeline with an expanse of therapeutic candidates in numerous indications. ImmunityBio’s…

Click here to view the original article.